Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2018-06-13 Director's Dealing
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-06-13 English
FORM 4 SUBMISSION
Director's Dealing
2018-06-01 English
FORM 3 SUBMISSION
Director's Dealing
2018-06-01 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Protagonist Therapeutics, Inc. It includes disclosures about the adoption of an inducement plan (stock option plan for new employees), results of the 2018 Annual Meeting of Stockholders including voting results for director elections and ratification of the independent auditor, and references to exhibits related to the inducement plan. The key content is about changes in board-related matters (director elections) and compensatory arrangements for officers. There are no financial statements or detailed financial results presented, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy statement or voting results announcement alone, but includes management and board changes and related plan adoption. The primary focus is on board/management information and related governance actions. Therefore, the best fitting category is Board/Management Information (MANG).
2018-05-31 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Protagonist Therapeutics, Inc. It is a registration statement under the Securities Act of 1933 for the registration of securities to be issued under an inducement plan. The document includes details about the securities to be registered, indemnification of directors and officers, incorporation by reference of other SEC filings, and exhibits related to the registration. It is not an annual report, earnings release, or any other financial report but a capital market filing related to securities registration. According to the filing definitions, this type of document is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit into other specific categories like capital/financing update or share issue/capital change, which are more specific to actual issuance or financing events rather than registration statements. The document length and content confirm it is a full registration statement, not a brief announcement or certification.
2018-05-30 English
THE SCHEDULE 13G
Major Shareholding Notification
2018-05-24 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.